Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Barlati

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 31, 2021
The impact of the Covid-19 pandemic on patients with schizophreniaAntonio Vita, Stefano Barlati
Current Opinion in Psychiatry|February 24, 2018
Recovery from schizophrenia: is it possible?Antonio Vita, Stefano Barlati
Frontiers in Psychiatry|April 6, 2019
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health ServicesAntonio Vita, Stefano Barlati
Brain Sciences|February 26, 2025
Brain Stimulation for Psychiatric Disorders: Emerging Evidence and New PerspectivesJacopo Lisoni, Stefano Barlati
Psychiatry Research|August 11, 2024
Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophreniaAntonio Vita, Gabriele Nibbio, Stefano Barlati
Schizophrenia Bulletin Open|August 15, 2024
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future PerspectivesAntonio Vita, Gabriele Nibbio, Stefano Barlati
Current Opinion in Psychiatry|February 27, 2024
Evidence-based psychosocial interventions in schizophrenia: a critical reviewStefano Barlati, Gabriele Nibbio, Antonio Vita
Current Opinion in Psychiatry|February 15, 2021
Schizophrenia during the COVID-19 pandemicStefano Barlati, Gabriele Nibbio, Antonio Vita
Frontiers in Psychiatry|November 28, 2024
Editorial: Unveiling the neurobiological underpinnings of cognitive dysfunction in patients with schizophreniaTomiki Sumiyoshi, Luca De Peri, Stefano Barlati
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 13, 2022
Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical reviewAlessandra Minelli, Stefano Barlati, Bernhard T Baune, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 31, 2021
The impact of the Covid-19 pandemic on patients with schizophreniaAntonio Vita, Stefano Barlati
Current Opinion in Psychiatry|February 24, 2018
Recovery from schizophrenia: is it possible?Antonio Vita, Stefano Barlati
Frontiers in Psychiatry|April 6, 2019
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health ServicesAntonio Vita, Stefano Barlati
Brain Sciences|February 26, 2025
Brain Stimulation for Psychiatric Disorders: Emerging Evidence and New PerspectivesJacopo Lisoni, Stefano Barlati
Psychiatry Research|August 11, 2024
Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophreniaAntonio Vita, Gabriele Nibbio, Stefano Barlati
Schizophrenia Bulletin Open|August 15, 2024
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future PerspectivesAntonio Vita, Gabriele Nibbio, Stefano Barlati
Current Opinion in Psychiatry|February 27, 2024
Evidence-based psychosocial interventions in schizophrenia: a critical reviewStefano Barlati, Gabriele Nibbio, Antonio Vita
Current Opinion in Psychiatry|February 15, 2021
Schizophrenia during the COVID-19 pandemicStefano Barlati, Gabriele Nibbio, Antonio Vita
Frontiers in Psychiatry|November 28, 2024
Editorial: Unveiling the neurobiological underpinnings of cognitive dysfunction in patients with schizophreniaTomiki Sumiyoshi, Luca De Peri, Stefano Barlati
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 13, 2022
Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical reviewAlessandra Minelli, Stefano Barlati, Bernhard T Baune, et al.
Pageof 14